Phathom Pharmaceuticals

PHATNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$691.703 M

$8.55 +1.91%

Close of 7 Aug 2026

Revenue

$175.1M

#2345 by revenue

Earnings

-$221.3K

Loss-making

Shares outstanding

80,900,934

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#187Evotec SEEVO$711.5M
#188Ironwood PharmaceuticalsIRWD$711.1M
#189Phathom PharmaceuticalsPHAT$691.7M
#190Zevra TherapeuticsZVRA$686.5M
#191NeurogeneNGNE$682.2M

Where these numbers come from

Share counts and financials for Phathom Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.